Genev Ivo K, Tobin Matthew K, Zaidi Saher P, Khan Sajeel R, Amirouche Farid M L, Mehta Ankit I
Department of Neurosurgery, University of Illinois at Chicago, Chicago, Illinois, United Sates.
Ivo Genev and Matthew Tobin equally contributed to this work.
Global Spine J. 2017 Feb;7(1):71-82. doi: 10.1055/s-0036-1583288. Epub 2017 Feb 1.
Narrative review.
Despite the numerous treatment options for vertebral compression fractures, a consensus opinion for the management of patients with these factures has not been established. This review is meant to provide an up-to-date overview of the most common treatment strategies for compression fractures and to suggest possible routes for the development of clearer treatment guidelines.
A comprehensive database search of PubMed was performed. All results from the past 30 years were obtained and evaluated based on title and abstract. The full length of relevant studies was analyzed for level of evidence, and the strongest studies were used in this review.
The major treatment strategies for patients with compression fractures are conservative pain management and vertebral augmentation. Despite potential adverse effects, medical management, including nonsteroidal anti-inflammatory drugs, calcitonin, teriparatide, and bisphosphonates, remains the first-line therapy for patients. Evidence suggests that vertebral augmentation, especially some of the newer procedures, have the potential to dramatically reduce pain and improve quality of life. At this time, balloon-assisted kyphoplasty is the procedure with the most evidence of support.
Based on current literature, it is evident that there is a lack of standard of care for patients with vertebral compression fractures, which is either due to lack of evidence that a procedure is successful or due to serious adverse effects encountered with prolonged treatment. For a consensus to be reached, prospective clinical trials need to be formulated with potential new biomarkers to assess efficacy of treatment strategies.
叙述性综述。
尽管椎体压缩骨折有多种治疗选择,但对于这些骨折患者的管理尚未形成共识性意见。本综述旨在提供压缩骨折最常见治疗策略的最新概述,并提出制定更清晰治疗指南的可能途径。
对PubMed进行全面的数据库检索。获取过去30年的所有结果,并根据标题和摘要进行评估。对相关研究的全文进行证据水平分析,本综述采用最强有力的研究。
压缩骨折患者的主要治疗策略是保守的疼痛管理和椎体强化。尽管存在潜在不良反应,但包括非甾体抗炎药、降钙素、特立帕肽和双膦酸盐在内的药物治疗仍是患者的一线治疗方法。有证据表明,椎体强化,尤其是一些较新的手术,有可能显著减轻疼痛并改善生活质量。目前,球囊辅助后凸成形术是最有证据支持的手术。
根据当前文献,很明显椎体压缩骨折患者缺乏护理标准,这要么是由于缺乏手术成功的证据,要么是由于长期治疗中遇到的严重不良反应。为达成共识,需要制定前瞻性临床试验,使用潜在的新生物标志物来评估治疗策略的疗效。